U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07865793) titled 'Clinical Study of Three-dimensional Lattice Radiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Advanced Solid Tumors' on March 31.

Brief Summary: This study aims to evaluate the safety and tolerability of lattice radiation therapy in combination with PD-1/PD-L1 inhibitors for patients with advanced solid tumors and large tumors, and to assess its efficacy.

Study Start Date: June 25, 2025

Study Type: INTERVENTIONAL

Condition: Advanced Malignant Solid Tumor

Intervention: COMBINATION_PRODUCT: lattice radiotherapy and PD-1/PD-L1 inhibitors

For large tumors, Lattice spatial segmentation radiotherapy should be perf...